An Align patent ruling in October 2026 found that Angelalign’s Torque Ridges feature infringed a European patent covering tooth-repositioning technology. The decision supports Align Technology’s intellectual-property rights, but Angelalign says it had already replaced the feature in Europe and that its current offering remains available.
Key Takeaways
- The Paris Local Division of the Unified Patent Court found that Torque Ridges infringed an Align patent.
- Angelalign says it replaced Torque Ridges in Europe with Pressure Points, launched in September 2026.
- Angelalign plans to comply with the ruling while reviewing its options; no financial impact was disclosed by Align.
Table of Contents
- What the Align patent ruling covers
- Angelalign says its European offering has already changed
- Commercial consequences remain unquantified
- Conclusion
What the Align patent ruling covers
The dispute concerns Angelalign’s Torque Ridges feature and an Align patent for repositioning a patient’s teeth according to an orthodontic treatment plan. The court rejected Angelalign’s challenges to the patent’s validity and ordered the recall and destruction of infringing products.
The ruling covers 17 European countries. It concerns the contested technology rather than establishing a blanket restriction on every Angelalign product. The decision remains subject to appeal.
| Item | Details |
|---|---|
| Court | Paris Local Division of the Unified Patent Court |
| Contested feature | Angelalign’s Torque Ridges |
| Replacement launch | Pressure Points entered the European market in September 2026 |
| Appeal status | Angelalign said it was evaluating its options; no completed appeal was identified |
Angelalign says its European offering has already changed
In its October 16 statement on the European product transition, Angelalign said it had discontinued Torque Ridges in Europe and replaced it with Pressure Points. The replacement launched in September, before the court decision.
Angelalign said the ruling does not affect the availability of its European offering. It also said customers in Spain, the UK and outside Europe, including the Americas and Asia, are unaffected.
The company disagrees with the decision and is reviewing its options. It nevertheless said it would comply, including returning products, while continuing clinical and technical support for orthodontists.
Commercial consequences remain unquantified
For Align, the decision upholds a patent associated with its Invisalign technology. However, a favorable infringement finding does not by itself establish a revenue gain or a loss of market share for its competitor.
Angelalign’s stated transition to Pressure Points limits what can be inferred about disruption to its current European business. Its assurances about continued availability are the company’s position, not a separate court finding about the replacement feature.
Align did not disclose a financial impact. The available information therefore does not quantify damages, compliance costs or any change in sales for either company.
Conclusion
The ruling establishes an infringement finding against Torque Ridges, while Angelalign says its replacement offering remains available. The next developments to watch are compliance with the order and whether Angelalign pursues an appeal; no financial outcome has been quantified.
Read More News
Disclaimer
This FinanceVelix article provides general information, not personalized financial, investment, legal, or tax advice. Market prices, interest rates and economic conditions can change; investments carry a risk of loss. Facts reflect the material available when published and may change. Check important information independently and consult a qualified professional when needed. Mentioning an asset, company, or service is not an endorsement.
